Is Fasting Good for Autoimmune Diseases?

Fasting shows genuine promise for autoimmune diseases in early research, but the honest picture is more complicated than the headlines suggest. Animal studies and small human trials point to reduced inflammation, shifts in immune cell populations that favor tolerance over attack, and even some tissue repair. A 2023 review in Autoimmunity Reviews concluded that intermittent fasting may benefit conditions like type 1 diabetes, rheumatoid arthritis, and lupus through several overlapping pathways, while also noting that evidence for many specific autoimmune diseases remains limited and inconclusive.¹ The mechanisms are real, the biology is plausible, and the clinical proof is still catching up.

How Fasting Rebalances Immune Cells

Autoimmune diseases are fundamentally a problem of misdirected immune activity. Your immune system attacks your own tissues as if they were foreign invaders. One of the most consistent findings in fasting research is that going without food shifts the balance between aggressive immune cells and the regulatory cells that keep them in check. In a mouse model of multiple sclerosis, intermittent fasting reduced the number of T cells that produce IL-17, a pro-inflammatory signal heavily implicated in autoimmune flares, while simultaneously increasing the proportion of regulatory T cells in the gut and lymph nodes.² Regulatory T cells act like referees, calming down immune responses that have gone too far. More referees and fewer aggressive players is exactly what you want in an autoimmune context.

A similar shift has been observed in lupus-prone mice. Fasting significantly expanded the population of functional regulatory T cells compared to mice eating freely, and these expanded cells were just as effective at suppressing overactive immune responses as the ones that existed before fasting.³ The mechanism appears to involve leptin, a hormone that drops sharply during fasting. Leptin normally inhibits the expansion of regulatory T cells, so when its levels fall, these protective cells get room to multiply.

Turning Down Inflammatory Signals

Beyond shuffling immune cell populations, fasting dampens the chemical messengers that drive inflammation. A meta-analysis of randomized controlled trials found that intermittent fasting regimens significantly reduced C-reactive protein (CRP), a widely used marker of systemic inflammation. The effect was more pronounced in people who were overweight and in studies lasting at least two months.⁴ CRP is not specific to any single autoimmune disease, but elevated CRP is a common thread linking rheumatoid arthritis, lupus, inflammatory bowel disease, and many other conditions. Bringing it down is broadly relevant.

Animal research fills in some of the finer details. A single 24-hour fast in rats reduced baseline levels of IL-1β, IL-6, and TNF-α across several tissue types, including visceral fat, a tissue that acts as a surprisingly active source of inflammatory chemicals.⁵ These cytokines are the same ones targeted by many expensive biologic drugs used to treat autoimmune diseases. The fact that a short fast can measurably reduce them raises an obvious question about whether dietary approaches could eventually complement medication, though no one is suggesting fasting replace proven treatments.

The Ketone Effect

When you fast long enough, your body starts burning fat for fuel and producing ketone bodies, the most important of which is beta-hydroxybutyrate (BHB). This molecule does more than just supply energy. Research published in Nature Medicine showed that BHB directly blocks the NLRP3 inflammasome, a protein complex inside immune cells that acts as a master switch for a potent inflammatory cascade.⁶ The NLRP3 inflammasome is involved in a wide range of autoimmune and inflammatory conditions, from gout to type 2 diabetes to multiple sclerosis. Blocking it is one of the most direct anti-inflammatory effects attributed to fasting.

This finding helps explain why the anti-inflammatory effects of fasting tend to be stronger than what you would expect from simple calorie reduction alone. The meta-analysis mentioned earlier found that intermittent fasting was more effective at reducing CRP than standard energy-restricted diets that cut the same number of calories.⁴ The on-off pattern of eating and fasting, with its periodic bursts of ketone production, appears to matter more than the total calorie deficit. Separate work confirmed that BHB also deactivates the NLRP3 inflammasome specifically in neutrophils, a type of white blood cell heavily involved in inflammatory flares.⁷

What Happens in the Gut

Your gut microbiome is deeply intertwined with immune function, and fasting reshapes it in ways that appear beneficial for autoimmune conditions. A study of people with metabolic syndrome who underwent a five-day fast found major shifts in core gut bacteria, with fasting enriching microbial pathways involved in producing propionate, a short-chain fatty acid with anti-inflammatory properties.⁸ Some of these shifts reversed after refeeding, but in participants whose blood pressure responded best to the intervention, the propionate-producing enrichment was even more pronounced, suggesting the gut changes may partly explain who benefits most from fasting.

Research in a Pakistani cohort comparing Ramadan fasting and intermittent fasting found that both approaches increased the abundance of bacteria generally considered beneficial, such as Lactobacillus and Prevotella, while decreasing potentially harmful genera like Desulfovibrio and Porphyromonas. Ramadan fasting also boosted several short-chain fatty acids and increased overall microbial diversity.⁹ Higher microbial diversity is consistently associated with lower autoimmune risk, while the loss of diversity is a common finding in people with inflammatory bowel disease, multiple sclerosis, and rheumatoid arthritis.

Disease-Specific Evidence

The strongest disease-specific data comes from multiple sclerosis research. In a mouse model of MS, periodic three-day cycles of a fasting-mimicking diet reduced the clinical severity of symptoms in all animals and completely reversed symptoms in about one in five. Beyond suppressing the autoimmune attack, the diet promoted the regeneration of oligodendrocyte precursor cells, the cells responsible for rebuilding the myelin sheath that MS destroys. Mice on the fasting-mimicking diet showed dramatically more new mature oligodendrocytes compared to controls, and significantly less cell death among both precursor and mature oligodendrocytes.¹⁰ This dual effect, suppressing the immune attack while actively promoting tissue repair, is unusual for any intervention and is what makes the MS findings particularly compelling.

For psoriasis, a phase IIb clinical trial compared patients who added intermittent fasting to standard treatment with those on standard treatment alone. At 28 weeks, roughly 54% of the fasting group maintained at least a 50% improvement in their psoriasis severity score compared to about 36% in the control group. The fasting group also showed significant reductions in IL-6, high-sensitivity CRP, and vascular endothelial growth factor, an inflammatory marker specific to the abnormal blood vessel growth seen in psoriatic skin.¹¹ This is one of the few controlled human trials in a specific autoimmune disease, and it suggests intermittent fasting can add measurable benefit on top of conventional therapy.

For lupus, the evidence remains largely preclinical. As mentioned earlier, fasting expanded regulatory T cells in lupus-prone mice, but large human trials have not been completed.³ The same is true for type 1 diabetes and thyroid-related autoimmune diseases like Hashimoto’s thyroiditis, where the theoretical rationale is solid but clinical data remain limited.

Stem Cell Regeneration and Immune Renewal

One of the more striking findings in fasting research has nothing to do with suppressing the existing immune system and everything to do with building a new one. Prolonged fasting cycles of 72 hours or more in mice triggered a roughly sixfold increase in newly generated blood-forming stem cells in the bone marrow. These stem cells are the starting point for virtually every cell in the immune system.¹² The mechanism involves a drop in IGF-1, a growth hormone signal that normally keeps stem cells dormant. When IGF-1 drops during fasting, dormant stem cells wake up and begin dividing.

The potential implications for autoimmune disease are significant. If fasting followed by refeeding can trigger a partial reset of the immune system, generating fresh immune cells that have not been trained to attack the body’s own tissues, it could theoretically reduce the autoimmune burden over time. Cycles of prolonged fasting followed by refeeding have been shown to stimulate this regenerative process and rejuvenate aged stem cells in mice.¹³ Whether this translates meaningfully to humans with established autoimmune diseases is not yet clear, but the concept of using fasting as a form of immune renewal is being actively investigated.

The Cortisol Complication

Fasting is a physiological stressor, and your body responds accordingly. A meta-analysis of 13 studies found that fasting significantly increases cortisol, the body’s primary stress hormone. The effect was strongest during actual fasting and during the initial days of severe caloric restriction, with cortisol levels trending back toward baseline after several weeks.¹⁴ This matters for autoimmune disease because cortisol has a complicated relationship with immune function. In the short term, elevated cortisol is immunosuppressive, which might actually help during a flare. But chronically elevated cortisol can disrupt immune regulation, worsen gut permeability, and interfere with sleep, all of which can aggravate autoimmune conditions.

Adding another layer, the cortisol response to fasting differs between men and women. Research found that fasting significantly increased free cortisol in men but not in women, and shifted the balance between active cortisol and its inactive form differently across sexes.¹⁵ Since many autoimmune diseases disproportionately affect women, this sex difference deserves attention when interpreting the overall evidence.

Fasting Affects Men and Women Differently

The cortisol difference is just one piece of a larger pattern. Mouse studies reveal that the immune response to intermittent fasting is sexually dimorphic in ways that go beyond stress hormones. Female mice showed a strong induction of type I interferon signaling during every-other-day fasting, a response that was largely absent in males. Removing the ovaries altered the interferon response, confirming that sex hormones directly modulate how the immune system reacts to fasting.¹⁶ Type I interferons are a double-edged sword in autoimmunity: they are critical for defending against viruses but are also major drivers of lupus and other conditions. A fasting regimen that ramps up interferon signaling could theoretically benefit some autoimmune diseases and worsen others, depending on the specific condition and the patient’s sex.

Earlier research had already established that testosterone amplifies the immune-modulatory stress response to fasting while estradiol dampens it. When female animals were given testosterone, their immune response to fasting looked like that of males, and vice versa.¹⁷ This means that the fasting protocols studied primarily in male animals, which constitute the bulk of preclinical research, may not produce the same results in females, and by extension, the women who make up the majority of autoimmune patients.

Safety Concerns and Medication Interactions

Fasting is not universally safe for people with autoimmune diseases, especially those on certain medications. A consensus panel on fasting and multiple sclerosis concluded that fasting is not considered safe for patients on high doses of anticonvulsants, antispastics, or corticosteroids, as well as those with active disease, during relapses, or with severe disability.¹⁸ Many autoimmune medications need to be taken with food to ensure proper absorption or to prevent gastrointestinal side effects. Methotrexate, a cornerstone drug in rheumatoid arthritis, is one example where skipping meals could alter drug levels unpredictably.

There are also practical concerns around blood sugar regulation. People with type 1 diabetes who fast face a heightened risk of both hypoglycemia and diabetic ketoacidosis, particularly if insulin doses are not carefully adjusted. Autoimmune conditions that affect the adrenal glands, like Addison’s disease, are another situation where fasting without medical supervision carries real danger, since cortisol regulation is already impaired.

Even for people whose disease is well controlled, the refeeding phase matters. Gut permeability can fluctuate during fasting and refeeding cycles, and for people with inflammatory bowel disease, how and what you eat when breaking a fast may be as important as the fast itself. Jumping straight into a large or inflammatory meal could provoke a flare in a gut that has been temporarily altered by the fasting period.

Why Most Evidence Is Still Preliminary

The gap between the exciting biology and the clinical reality is worth being honest about. Most of the strongest findings, the regulatory T cell expansion in lupus, the oligodendrocyte regeneration in MS, the stem cell renewal in the bone marrow, come from mouse models. Mice develop induced versions of human autoimmune diseases, and the fasting protocols used in rodent research (complete food withdrawal for days at a time) are far more extreme than anything practical for a person living with a chronic illness. The fasting-mimicking diets used in some studies attempt to bridge this gap by providing very low calories while still allowing some food intake, but human trials using these approaches are still small and short-term.

The psoriasis trial is an encouraging exception, offering controlled human data showing clinical improvement. But even that trial lasted less than a year, and autoimmune diseases are lifelong conditions. Whether intermittent fasting maintains its benefits over years, whether the disease rebounds after stopping, and whether the approach works equally well across different autoimmune conditions are all open questions. The 2023 review in Autoimmunity Reviews was careful to note that while the evidence for conditions like rheumatoid arthritis and type 1 diabetes is promising, data on MS, lupus, thyroid diseases, and psoriasis remains limited and inconclusive.¹

Different Fasting Approaches and What They Mean

Not all fasting is the same, and the type of protocol matters for what biological effects you are likely to trigger. Time-restricted eating, where you compress your meals into a window of eight to ten hours each day, is the mildest form and the most sustainable for most people. It can reduce inflammatory markers and improve metabolic health, but it may not produce enough ketone elevation to robustly activate the NLRP3 inflammasome-blocking effect of BHB.

Alternate-day fasting and the 5:2 approach (eating normally five days per week and restricting heavily on two) push the body further into fat-burning territory and are closer to the intermittent fasting protocols studied in the inflammatory marker meta-analysis. Prolonged fasting, going 48 to 72 hours without food, is what triggered the stem cell regeneration seen in mouse studies, but this is also the protocol most likely to spike cortisol and is impractical for most patients without medical oversight. Fasting-mimicking diets, which allow roughly 800 calories per day of specific nutrients for several days, were designed to capture some benefits of prolonged fasting while remaining safer and more tolerable. These are the protocols behind the MS and IBD animal studies.

The right approach for someone with an autoimmune disease depends on disease activity, medications, body composition, and individual tolerance. What is clear from the research is that the “fasting” in these studies is not a single intervention any more than “exercise” is a single intervention. The dose, timing, and type all influence the outcome, and the field has not yet converged on an optimal protocol for any specific autoimmune condition.